Skip to content

Moon Surgical · Medical devices (surgical robotics) · France and United States (Paris and San Francisco)

Moon Surgical: FDA-cleared ScoPilot camera control running on NVIDIA Holoscan

Moon Surgical's ScoPilot feature lets the laparoscope on its Maestro surgical robot follow a chosen instrument tip, running locally on NVIDIA Holoscan. It received FDA clearance in March 2025; Moon Surgical says Maestro had been used in more than 1,100 patients.

Status
In production
Status as of
18 Mar 2025
NVIDIA technologies
NVIDIA Holoscan SDK

The challenge

In laparoscopic surgery the surgeon needs a stable, well-placed camera view while both hands hold instruments. Moon Surgical's goal with ScoPilot is to let the surgeon control the camera without letting go of the instruments.

ScoPilot runs during surgery, so it processes the laparoscope video locally on Maestro through Holoscan, which Moon Surgical describes as a real-time platform for AI in the operating room, and it needed FDA clearance.1

What was implemented

ScoPilot is an on-demand feature of Moon Surgical's Maestro System. Moon Surgical says the commercial Maestro System was FDA-cleared in June 2024; the FDA database shows Maestro's first 510(k) clearance (K221410) in December 2022. When switched on, the laparoscope held by Maestro follows the tip of an instrument the surgeon chooses.

ScoPilot runs locally on the Maestro System using NVIDIA Holoscan, NVIDIA's real-time sensor processing platform for medical and edge AI applications. Moon Surgical says it is the first AI application to run during surgery on a commercially available surgical robot with Holoscan, a claim we have not verified independently. Maestro also pairs its sensing with NVIDIA-accelerated computing to collect surgical data for future features.

Separately, NVIDIA's March 2025 developer blog lists Moon Surgical among early adopters of Isaac for Healthcare, prototyping autonomous robot setup. That work is described as prototyping, not a cleared product.

We found no NVIDIA or Moon Surgical statement that the company is an NVIDIA Inception member, so it is not described as one here.12345

Reported outcomes

  • ScoPilot received FDA clearance16

    FDA clearance, March 2025

    Measured
  • Maestro System used to treat more than 1,100 patients in the US and Europe12

    1,100+ patients (base system, not ScoPilot alone)

    Measured

Each outcome links to its source; the label there says whether the company, NVIDIA or a third party reported it.

What others can learn, and the limits

What others can learn: a narrowly scoped AI feature (camera follows one instrument) running on local hardware is a realistic path to regulatory clearance for a startup, and building on an existing real-time platform such as Holoscan avoids writing the sensor pipeline from scratch. Limits: published results are a regulatory milestone and a patient count for the base Maestro system; no clinical outcome or efficiency data for ScoPilot itself was published in the sources reviewed. Medical device clearance depends on the device, its intended use and the market, so another product cannot assume the same path. A device that does not need real-time video processing in the room may not need Holoscan at all.

Explore a similar project

Use the Startup-to-NVIDIA Match with your own assumptions. Results are independent of this case.

Open the lab

Sources

  1. Moon Surgical receives FDA clearance for ScoPilot on Maestro, powered by NVIDIA Holoscan (company release, linked from moonsurgical.com) (opens in a new tab)Moon Surgical · Customer-reported
  2. Moon Surgical receives FDA clearance for ScoPilot on Maestro (portfolio news) (opens in a new tab)Sofinnova Partners (Moon Surgical investor; reprint of the company's release) · Customer-reported
  3. Introducing NVIDIA Isaac for Healthcare, an AI-Powered Medical Robotics Development Platform (opens in a new tab)NVIDIA · Vendor-reported
  4. Moon Surgical (company website, news list) (opens in a new tab)Moon Surgical · Customer-reported
  5. FDA 510(k) Premarket Notification database: K221410 (opens in a new tab)U.S. Food and Drug Administration · Independently verified
  6. FDA 510(k) Premarket Notification database: K242323 (opens in a new tab)U.S. Food and Drug Administration · Independently verified

Fill out the form below to request your copy.

Name(Required)